IRIS
DANESE, Silvio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.617
AS - Asia 15.958
EU - Europa 5.122
SA - Sud America 3.124
AF - Africa 851
OC - Oceania 57
Continente sconosciuto - Info sul continente non disponibili 46
AN - Antartide 1
Totale 53.776
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.040
SG - Singapore 10.232
BR - Brasile 2.595
CN - Cina 2.341
VN - Vietnam 1.530
FI - Finlandia 1.022
IE - Irlanda 718
IT - Italia 643
NG - Nigeria 594
DE - Germania 556
FR - Francia 480
HK - Hong Kong 407
GB - Regno Unito 401
CA - Canada 360
IN - India 263
NL - Olanda 255
SE - Svezia 209
AR - Argentina 191
TR - Turchia 173
BD - Bangladesh 168
RU - Federazione Russa 146
MX - Messico 125
IQ - Iraq 118
ES - Italia 100
BE - Belgio 98
PL - Polonia 89
UA - Ucraina 85
IL - Israele 83
JP - Giappone 82
ZA - Sudafrica 82
EC - Ecuador 79
ID - Indonesia 70
CL - Cile 66
CO - Colombia 56
RO - Romania 56
PK - Pakistan 52
SA - Arabia Saudita 48
VE - Venezuela 48
AU - Australia 47
PH - Filippine 42
A2 - ???statistics.table.value.countryCode.A2??? 41
PY - Paraguay 39
EG - Egitto 38
UZ - Uzbekistan 38
MA - Marocco 36
CZ - Repubblica Ceca 35
GR - Grecia 34
JO - Giordania 30
MY - Malesia 30
IR - Iran 28
AE - Emirati Arabi Uniti 27
LT - Lituania 27
NP - Nepal 25
KR - Corea 23
AT - Austria 21
CH - Svizzera 21
DZ - Algeria 21
TN - Tunisia 21
KE - Kenya 20
KZ - Kazakistan 20
AL - Albania 18
AZ - Azerbaigian 18
JM - Giamaica 18
PE - Perù 18
UY - Uruguay 18
NO - Norvegia 17
MD - Moldavia 15
PT - Portogallo 15
CR - Costa Rica 14
LB - Libano 13
DK - Danimarca 12
DO - Repubblica Dominicana 11
ET - Etiopia 11
SY - Repubblica araba siriana 11
KG - Kirghizistan 10
BO - Bolivia 9
BY - Bielorussia 9
GT - Guatemala 9
HN - Honduras 9
OM - Oman 9
CY - Cipro 8
PA - Panama 8
SN - Senegal 8
TH - Thailandia 8
HU - Ungheria 7
PS - Palestinian Territory 7
NI - Nicaragua 6
NZ - Nuova Zelanda 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
BN - Brunei Darussalam 5
QA - Qatar 5
SI - Slovenia 5
AO - Angola 4
BB - Barbados 4
BG - Bulgaria 4
GE - Georgia 4
GY - Guiana 4
KH - Cambogia 4
KW - Kuwait 4
Totale 53.702
Salva come PNG Salva come JPEG
Città #
Singapore 4.877
Chandler 4.186
Wilmington 4.026
Ashburn 1.644
San Mateo 1.631
The Dalles 1.599
Ann Arbor 1.255
Dallas 1.172
Shanghai 1.126
Helsinki 1.018
San Jose 869
Dublin 712
Lawrence 712
Princeton 712
Leawood 702
Boardman 699
New York 589
Benin City 588
Ho Chi Minh City 509
Beijing 461
Paris 404
Hanoi 397
Woodbridge 378
Hong Kong 375
Fairfield 365
Los Angeles 247
Amsterdam 237
Santa Clara 233
Milan 217
São Paulo 201
London 193
Toronto 192
Columbus 167
Seattle 166
Buffalo 109
Phoenix 104
Norwalk 103
Orem 96
San Diego 94
Kocaeli 92
Rio de Janeiro 90
Brussels 88
Council Bluffs 82
Belo Horizonte 69
Rome 69
Da Nang 62
Warsaw 60
Haiphong 58
Falkenstein 56
Tokyo 55
Brasília 53
Houston 49
Chennai 48
Chicago 48
Munich 48
Campinas 47
Brooklyn 46
Redwood City 46
Montreal 45
Pune 41
Johannesburg 40
Baghdad 37
Mexico City 37
Frankfurt am Main 36
Monmouth Junction 36
Moscow 36
Atlanta 35
Curitiba 34
Falls Church 34
Abbiategrasso 33
Clearwater 33
Naples 32
Tashkent 32
Porto Alegre 31
San Francisco 31
Cambridge 29
Amman 28
Charlotte 28
Des Moines 27
Las Vegas 27
Biên Hòa 26
Brno 26
Guayaquil 26
Mumbai 26
Boston 25
Manchester 25
Quito 25
Dhaka 24
Hillsboro 24
Salvador 24
Stockholm 24
Guarulhos 22
Ottawa 22
Goiânia 21
Hangzhou 21
Redmond 21
Denver 20
Istanbul 20
Jakarta 20
Miami 20
Totale 35.735
Salva come PNG Salva come JPEG
Nome #
Biological agents for ulcerative colitis : Hypes and hopes 312
Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion 274
Multimodal treatment of perianal fistulas in Crohn's disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial 199
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 160
Crohn's disease 155
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 151
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience. 148
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations 146
Budesonide : teaching an old dog new tricks for inflammatory bowel disease treatment 137
Balanced propofol sedation administered by nonanesthesiologists : the first Italian experience 137
All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis 134
The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation 133
Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease 131
A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild-to-moderate ulcerative colitis 131
Endoscopic flexible treatment of Zenker's diverticulum: a modification of the needle-knife technique 130
Review article: optimal preparation for surgery in Crohn's disease 127
A Prospective Comparison Between 1.5t Magnetic Resonance and 3t Magnetic Resonance in Ileo-Colonic Crohn's Disease: A Single Center Experience 126
A liophylized and inactivated colture of Lactobacillus acidophilus increases Helicobacter pylori eradication rate 125
Adalimumab in Crohn's disease : tips and tricks after 5 years of clinical experience 124
New Drug Delivery Systems in Inflammatory Bowel Disease: MMX (TM) and Tailored Delivery to the Gut 122
Darvadstrocel for the treatment of patients with perianal fistulas in Crohn's disease 122
Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease 122
A PROSPECTIVE, SINGLE CENTER STUDY OF ENDOSCOPIC SUBMUCOSAL DISSECTION OF RECTAL LST LESIONS > 3 CM BY USING AN INNOVATIVE CONCEPT OF INJECTING AND CUTTING: THE WATER-JET HYBRID-KNIFE (ESD-H) 120
Adalimumab is effective in achieving clinical and endoscopic long-term deep remission : a case report 119
Intestinal microbiota in inflammatory bowel disease: Friend of foe? 119
A NEW TOOL FOR PRE-COLONOSCOPY DYING OF THE COLONIC MUCOSA WITH ORAL MULTI MATRIX RELEASE TECHNOLOGY (MMX (R))-RELEASED METHYLENE BLUE: A PRELIMINARY STUDY 119
Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study 119
Laparoscopic Surgery for Recurrent Crohn's Disease 118
Ulcerative Colitis 118
Role of bowel ultrasound as a predictor of surgical recurrence of Crohn's disease 117
New insights into inflammatory bowel disease pathophysiology: Paving the way for novel therapeutic targets 116
Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease 116
A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies 115
Anti-adhesion molecule therapies in inflammatory bowel disease: touch and go 114
VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis 113
Imaging Modalities for Perianal Crohn's Disease 111
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study 111
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial 111
Colifagina, a novel preparation of 8 lysed bacteria ameliorates experimental colitis 111
Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease 111
Risk of postoperative recurrence and postoperative management of Crohn's disease 110
Colitis-associated cancer: the dark side of inflammatory bowel disease 110
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial 110
Risk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study. 110
Adalimumab in active ulcerative colitis: A "real-life" observational study 109
Inflammatory bowel disease: the role of environmental factors 108
Bowel damage as assessed by the Lémann Index is reversible on anti-TNF therapy for Crohn's disease 108
Biological therapies for inflammatory bowel disease: Research drives clinics 107
Internet use among inflammatory bowel disease patients: an Italian multicenter survey 107
Second-Generation Corticosteroids for the Treatment of Crohn's Disease and Ulcerative Colitis: More Effective and Less Side Effects? 106
A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis 106
PK, PD, and interactions: the new scenario with JAK inhibitors and S1P receptor modulators, two classes of small molecule drugs, in IBD 106
Accuracy of Diffusion-weighted Magnetic Resonance Imaging in Detecting Mucosal Healing and Treatment Response, and in Predicting Surgery, in Crohn's Disease 106
Inflammation and coagulation in inflammatory bowel disease: The clot thickens 105
Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice 105
Accuracy of a new diagnostic tool in deep infiltrating endometriosis: Positron emission tomography-computed tomography with 16 alpha-[18F]fluoro-17 beta-estradiol 105
Evolving strategies and goals of treatment in ulcerative colitis 104
Ulcerative Colitis and Crohn's Disease Have Similar Burden and Goals for Treatment 104
Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study 104
VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease 103
Immune regulation by microvascular endothelial cells: Directing innate and adaptive immunity, coagulation, and inflammation 103
mTOR-Dependent Stimulation of IL20RA Orchestrates Immune Cell Trafficking through Lymphatic Endothelium in Patients with Crohn's Disease 103
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients 102
Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa 102
Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort study 101
Helicobacter pylori eradication down-regulates matrix metalloproteinase-9 expression in chronic gastritis and gastric ulcer 101
Prevalence of Bowel Damage Assessed by Cross-Sectional Imaging in Early Crohn's Disease and its Impact on Disease Outcome. 101
IBD Of mice and men-shedding new light on IL-13 activity in IBD 100
Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease 100
Balanced Propofol Sedation (BPS) Administered by Non-Anesthesiologists vs Midazolam Alone for Endoscopic Procedure in Patients With IBD: A Single Center Open-Label Trial 100
Dysregulated intracellular redox equilibrium in intestinal lamina propria T cells (LPT) contributes to mucosal inflammation 99
Impact of Medications on Radiologic Disease Activity and Bowel Damage in Crohn's Disease: A Prospective Longitudinal MRI Study 99
WallFlex colonic stent placement for management of malignant colonic obstruction : a prospective study at two centers 99
MFSD2A Promotes Endothelial Generation of Inflammation-resolving Lipid Mediators and Reduces Colitis in Mice 99
A prospective multi-centre observational cohort study assessing the effectiveness of Budesonide MMX® for mild-to-moderate ulcerative colitis 99
A Multidisciplinary Approach to Rectal Cancer Treatment in Ulcerative Colitis Results in High Rate of Restorative Minimally Invasive Surgery 98
Vascular involvement in inflammatory bowel disease: Pathogenesis and clinical aspects 98
Management of IBD during the COVID-19 outbreak: resetting clinical priorities 98
COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy 98
JAK selectivity for inflammatory bowel disease treatment: does it clinically matter? 97
Review article: causative factors and the clinical management of patients with Crohn's disease who lose response to anti-TNF-alpha therapy 97
Thrombomodulin-activated protein C-endothelial protein C receptor pathway: A novel anti-inflammatory system in IBD 97
Perception of reproductive health in women with inflammatory bowel disease 97
Emerging biologics in the treatment of inflammatory bowel disease : what is around the corner? 96
Development and validation of the Nancy histological index for UC 96
Endoscopic mucosal resection for early colorectal neoplasia: pathologic basis, procedures, and outcomes. 96
Efficacy of Vedolizumab in Fistulising Crohn's Disease: Exploratory Analyses of Data from GEMINI 2 96
Impact of Tumour Necrosis Factor Antagonists on Avoiding Surgery in Stricturing Crohn's Disease: A Tertiary Center Real-Life Experience 95
Adalimumab in ulcerative colitis: Ready for prime time 95
Methotrexate for Corticosteroid- Dependent Ulcerative Colitis: Results of a Placebo Randomized Controlled Trial 95
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease : a prospective study 95
Surgical rates in the era of biological therapy: up, down or unchanged? 94
Role of the vascular and lymphatic endothelium in the pathogenesis of inflammatory bowel disease: 'brothers in arms' 94
Review article: Inherited thrombophilia in inflammatory bowel disease 93
Systematic review with network meta-analysis: comparative efficacy and safety of budesonide and mesalazine (mesalamine) for Crohn's disease 93
Psychological Characteristics of Inflammatory Bowel Disease Patients: A Comparison Between Active and Nonactive Patients 93
Effect of Immunosuppression on Immune Response to Pneumococcal Vaccine in Inflammatory Bowel Disease: A Prospective Study 93
Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis 93
Treatment with a Urokinase Receptor-derived Cyclized Peptide Improves Experimental Colitis by Preventing Monocyte Recruitment and Macrophage Polarization 93
Platelets in inflammatory bowel disease: Clinical, pathogenic, and therapeutic implications 93
Totale 11.448
Salva come PNG Salva come JPEG
Categoria #
all - tutte 381.831
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 381.831
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021865 0 0 0 0 0 0 0 0 0 0 0 865
2021/20224.317 216 55 132 869 39 48 127 554 391 708 943 235
2022/202310.508 1.606 443 1.059 1.207 896 952 32 939 1.827 865 553 129
2023/20245.131 439 529 1.152 220 179 613 231 276 98 89 425 880
2024/20257.671 223 196 74 214 228 939 357 975 984 1.836 811 834
2025/202619.355 2.911 1.131 1.322 1.818 576 645 5.910 1.045 1.063 1.153 635 1.146
Totale 54.494